Table of Contents
Scope and Themes
-
- What you need to know
- Definition
- Abbreviations and terms
- Abbreviations
- Terms
Executive Summary
-
- Snapshot of the market
- Demographic changes help drive market
- Increased work stress
- Consumer ads for prescription drugs soar
- Lack of health insurance and cross-channel competition hold back market
- Sanofi-Aventis (Ambien’s) dominance begins to wane
- Massive growth in direct-to-consumer adspend from 2004-05
- Retail activity
- Incidence of sleep issues and severity
- Use of prescription and OTC medications for sleep issues
- Remedies for sleeplessness
- Reasons for sleep disturbance
- Choice of prescription or OTC sleep aids
- Sales strong for now, but will probably start declining sometime in 2008
Market Drivers
-
- Prevalence of sleep disorders
-
- Figure 1: Sleep habits, by age, September 2006
- Baby Boomers have higher use of sleep aids
-
- Figure 2: Incidence of use of medication for insomnia/sleep disorders, by age, May 2005-June 2006
-
- Figure 3: Total U.S. population, by age group, 2001-11
- Females have more sleep issues
-
- Figure 4: Total U.S. female population, by age group, 2001-11
- Increased work hours lead to increased stress and sleeplessness
- Pronounced spend on direct-to-consumer (DTC) ads
- Lack of access to health insurance
- Even those with access to employer-sponsored plans leaving system
- Competition from night time analgesics
-
- Figure 5: Total U.S. retail sales of PM analgesics, at current and constant prices, 2000-04
Market Size and Trends
-
- Market size
-
- Figure 6: Total U.S. retail sales of sleep aids, at current and constant prices, 2001-06
- Figure 7: Graph: Total U.S. retail sales of sleep aids, at current and constant prices, 2001-06
Market Segmentation
-
- Prescription sales dominate the market
-
- Figure 8: U.S. sales of sleep aids, by sector, 2004 and 2006
- Prescription sleep aids
-
- Figure 9: U.S. sales of prescription sleep aids, at current and constant prices, 2001-06
- OTC sleep aid tablets
-
- Figure 10: U.S. FDM sales of OTC sleep aid tablets, at current and constant prices, 2001-06
- OTC sleep aid liquids
-
- Figure 11: U.S. FDM sales of OTC sleep aid liquids, at current and constant prices, 2001-06
Supply Structure
-
- Company and brand sales of sleep aids
- Introduction
- Prescription sleep aids
-
- Figure 12: Manufacturer brand sales of prescription sleep aids in the U.S., 2004 and 2005
- OTC sleep aids
-
- Figure 13: Manufacturer FDM brand sales of OTC sleep aids in the U.S., 2004 and 2006
- Company profiles—Prescription manufacturers
- Sanofi-Aventis
- Sepracor Inc.
- GlaxoSmithKline plc
- King Pharmaceuticals
- Takeda Pharmaceutical Company Limited
- Company profiles—OTC manufacturers
- GlaxoSmithKline
- Johnson & Johnson/McNeil
- Pfizer
Advertising and Promotion
-
- Introduction
-
- Figure 14: Prescription sleep aids, adspend, by brand, 2004 and 2005
- Ambien (Sanofi-Aventis)
- Overview
- Ambien CR
-
- Figure 15: Ambien Advertisement, 2006
- Lunesta (Sepracor)
- Overview
- Lunesta
-
- Figure 16: Lunesta Advertisement, 2006
- Rozerem (Takeda)
-
- Figure 17: Rozerem advertisement, 2006
- OTC brand ads
- MidNite Herbal Sleep Aid
-
- Figure 18: MidNite Herbal Advertisement, 2006
Retail Distribution
-
- Introduction
-
- Figure 19: U.S. FDM sales of OTC sleep aids, by channel, 2004 and 2006
- Drug stores
-
- Figure 20: U.S. drug store sales of sleep aids, at current and constant prices, 2001-06
- Supermarkets
-
- Figure 21: U.S. supermarket sales of sleep aids, at current and constant prices, 2001-06
- Mass merchandisers
-
- Figure 22: U.S. mass merchandiser sales of sleep aids, at current and constant prices, 2001-06
The Consumer
-
- Introduction
- Summary
- Incidence of sleep issues and severity
- Use of prescription and OTC medications for sleep issues
- Remedies for sleeplessness
- Reasons for sleep disturbance
- Choice of prescription or OTC sleep aids
- Incidence of anxiety or insomnia/sleep disorder
-
- Figure 23: Incidence of anxiety or insomnia/sleep disorder, May 2005-June 2006
-
- Figure 24: Incidence of anxiety or insomnia/sleep disorder, by gender, May 2005-June 2006
-
- Figure 25: Incidence of anxiety or insomnia/sleep disorder, by race/ethnicity, May 2005-June 2006
- Sleep habits
-
- Figure 26: Sleep habits, September 2006
-
- Figure 27: Sleep habits, by gender, September 2006
-
- Figure 28: Sleep habits, by age, September 2006
-
- Figure 29: Sleep habits, by employment status, September 2006
- Severity of insomnia/sleep disorder
-
- Figure 30: Severity of insomnia/sleep disorder, May 2005-June 2006
-
- Figure 31: Severity of insomnia/sleep disorder, by level of education attained, May 2005-June 2006
- Use of medication to treat anxiety or insomnia/sleep disorder
-
- Figure 32: Incidence of use of medication for insomnia/sleep disorders, May 2005-June 2006
-
- Figure 33: Incidence of use of medication for insomnia/sleep disorders, by gender, May 2005-June 2006
-
- Figure 34: Incidence of use of medication for insomnia/sleep disorders, by age, May 2005-June 2006
-
- Figure 35: Incidence of use of medication for insomnia/sleep disorders, by level of education attained, May 2005-June 2006
- Use of Ambien or Sonata
-
- Figure 36: Use of Ambien or Sonata—all prescription drug users, May 2005-June 2006
-
- Figure 37: Use of Ambien or Sonata—respondents with insomnia/sleep disorder, May 2005-June 2006
-
- Figure 38: Use of Ambien or Sonata—respondents with insomnia/sleep disorder, by gender, May 2005-June 2006
-
- Figure 39: Use of Ambien or Sonata—respondents with insomnia/sleep disorder, by level of education attained, May 2005-June 2006
- Remedies for insomnia
-
- Figure 40: Remedies for insomnia, September 2006
-
- Figure 41: Remedies for insomnia, by gender, September 2006
-
- Figure 42: Remedies for insomnia, by age, September 2006
-
- Figure 43: Remedies for insomnia, by education level attained, September 2006
-
- Figure 44: Remedies for insomnia, by employment status, September 2006
- Activities/room aids used to aid sleep
-
- Figure 45: Activities/room aids used to aid sleep, September 2006
-
- Figure 46: Activities/room aids used to aid sleep, by gender, September 2006
-
- Figure 47: Activities/room aids used to aid sleep, by marital status, September 2006
-
- Figure 48: Activities/room aids used to aid sleep, by age, September 2006
-
- Figure 49: Activities/room aids used to aid sleep, by household income, September 2006
-
- Figure 50: Activities/room aids used to aid sleep, by presence of children under age 18 in household, September 2006
-
- Figure 51: Activities/room aids used to aid sleep, by employment status, September 2006
- Reasons for sleep disturbance
-
- Figure 52: Reasons for sleep disturbance, September 2006
-
- Figure 53: Reasons for sleep disturbance, by gender, September 2006
-
- Figure 54: Reasons for sleep disturbance, by age, September 2006
-
- Figure 55: Reasons for sleep disturbance, by Hispanic origin, September 2006
-
- Figure 56: Reasons for sleep disturbance, by presence and number of children under age 18 in household, September 2006
-
- Figure 57: Reasons for sleep disturbance, by level of education attained, September 2006
- Concerns/opinions regarding sleep aids
-
- Figure 58: Concerns/opinions regarding sleep aids, September 2006
-
- Figure 59: Concerns/opinions regarding sleep aids, by age, September 2006
-
- Figure 60: Concerns/opinions regarding sleep aids, by employment status, September 2006
-
- Figure 61: Concerns/opinions regarding sleep aids, by Hispanic status, September 2006
- Side effects of sleep aids
-
- Figure 62: Side effects of sleep aids, September 2006
-
- Figure 63: Side effects of sleep aids, by age, September 2006
-
- Figure 64: Side effects of sleep aids, by number of people in household, September 2006
- Reasons for choosing OTC over prescription sleep aids
-
- Figure 65: Reasons for choosing OTC over prescription sleep aids, September 2006
-
- Figure 66: Reasons for choosing OTC over prescription sleep aids, by household income, September 2006
- Reasons for choosing prescription sleep aids over OTC
-
- Figure 67: Reasons for choosing prescription sleep aids over OTC, September 2006
-
- Figure 68: Reasons for choosing prescription sleep aids over OTC, by gender, September 2006
-
- Figure 69: Reasons for choosing prescription sleep aids over OTC, by employment status, September 2006
Future and Forecast
-
- Future trends
- Aging population drives overall prescription sales
- Concerns for safety could slow sales of prescription sleep aids
- Loss of patent protection for Ambien will negatively affect market—at some point soon
- Competition from natural sleep aids such as melatonin and Valerian
- Market forecast
- Sleep aids
-
- Figure 70: Forecast of total U.S. sales of sleep aids, at current and constant prices, 2006-08
- Prescription sleep aids
-
- Figure 71: Forecast of U.S. sales of prescription sleep aids, at current and constant prices, 2006-08
- OTC sleep aids
-
- Figure 72: Forecast of U.S. FDM sales of OTC sleep aids, at current and constant prices, 2006-08
- Forecast factors
Appendix: Trade Associations
Appendix: New Product Briefs
-
- Walgreens: Extra Strength Acetaminophen PM
- Lil’ Drug Store Products: Legatrin PM
- CVS: Nighttime Sleep-Aid
Back to top